Pittard Christian

SEC Form 4 insider trading activity

Pittard Christian has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Dec 18, 2025.

On the most recent filing, Pittard Christian is listed as Director at abrdn Life Sciences Investors. Inside the rolling window, Pittard Christian reported 1 open-market purchase totaling $134K in HQL and no open-market sales.

Companies traded

Other insiders at HQL

Insider Buying

$134K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
HQLPurchase$134KDec 18SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Pittard Christian made?

Pittard Christian has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2025.

Which companies does Pittard Christian trade?

Pittard Christian has filed SEC Form 4 disclosures for 1 company, including HQL.

When was Pittard Christian's most recent SEC Form 4 filing?

Pittard Christian's most recent SEC Form 4 filing on Tracefour is dated Dec 18, 2025.

What is Pittard Christian's total buy and sell value in the current window?

Inside the rolling retention window, Pittard Christian bought $134K and sold $0 based on SEC Form 4 filings.

What was Pittard Christian's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 7,923 HQL shares on 2025-12-16, worth $134K, per SEC Form 4 filings.